222 related articles for article (PubMed ID: 23920225)
21. Tenofovir-induced Fanconi syndrome in chronic hepatitis B monoinfected patients that reverted after tenofovir withdrawal.
Viganò M; Brocchieri A; Spinetti A; Zaltron S; Mangia G; Facchetti F; Fugazza A; Castelli F; Colombo M; Lampertico P
J Clin Virol; 2014 Dec; 61(4):600-3. PubMed ID: 25453573
[TBL] [Abstract][Full Text] [Related]
22. Denosumab improves clinical manifestations of hypophosphatemic osteomalacia by adefovir-induced Fanconi syndrome: a case report.
Kunii T; Iijima T; Jojima T; Shimizu M; Kase M; Sakurai S; Kogai T; Usui I; Aso Y
J Med Case Rep; 2019 Apr; 13(1):99. PubMed ID: 31003599
[TBL] [Abstract][Full Text] [Related]
23. Nephrotoxicity, including acquired Fanconi's syndrome, caused by adefovir dipivoxil - is there a safe dose?
Law ST; Li KK; Ho YY
J Clin Pharm Ther; 2012 Apr; 37(2):128-31. PubMed ID: 21714795
[TBL] [Abstract][Full Text] [Related]
24. Osteomalacia induced by adefovir in patient with hepatitis B.
Nathali Rivas Zavaleta M; Guayambuco Romero S; Calabozo Raluy M; Pérez Ruiz F
Reumatol Clin; 2014; 10(2):120-1. PubMed ID: 23664308
[TBL] [Abstract][Full Text] [Related]
25. Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk?
Gill US; Zissimopoulos A; Al-Shamma S; Burke K; McPhail MJ; Barr DA; Kallis YN; Marley RT; Kooner P; Foster GR; Kennedy PT
J Infect Dis; 2015 Feb; 211(3):374-82. PubMed ID: 25156561
[TBL] [Abstract][Full Text] [Related]
26. Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient.
Perrot S; Aslangul E; Szwebel T; Caillat-Vigneron N; Le Jeunne C
J Clin Rheumatol; 2009 Mar; 15(2):72-4. PubMed ID: 19265350
[TBL] [Abstract][Full Text] [Related]
27. Tenofovir-induced osteomalacia.
Wanner DP; Tyndall A; Walker UA
Clin Exp Rheumatol; 2009; 27(6):1001-3. PubMed ID: 20149322
[TBL] [Abstract][Full Text] [Related]
28. Low-dose adefovir dipivoxil-induced hypophosphatemia osteomalacia in five chronic hepatitis B virus-infected patients. Is low-dose adefovir dipivoxil-induced nephrotoxicity completely reversible?
Qian YY; Dai ZJ; Ruan LY; Pan YJ; Jin J; Shi MT; Zhu YX; Wu CM
Drug Des Devel Ther; 2019; 13():1127-1133. PubMed ID: 31118563
[TBL] [Abstract][Full Text] [Related]
29. Tenofovir disoproxil fumarate for the treatment of hepatitis B infection.
Adusumilli S
Drugs Today (Barc); 2009 Sep; 45(9):679-85. PubMed ID: 19956809
[TBL] [Abstract][Full Text] [Related]
30. The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy.
Parsonage MJ; Wilkins EG; Snowden N; Issa BG; Savage MW
HIV Med; 2005 Sep; 6(5):341-6. PubMed ID: 16156882
[TBL] [Abstract][Full Text] [Related]
31. Pathologic Femoral Neck Fracture Due to Fanconi Syndrome Induced by Adefovir Dipivoxil Therapy for Hepatitis B.
Lee YS; Kim BK; Lee HJ; Dan J
Clin Orthop Surg; 2016 Jun; 8(2):232-6. PubMed ID: 27247753
[TBL] [Abstract][Full Text] [Related]
32. Acquired Fanconi's syndrome associated with tenofovir therapy.
Mathew G; Knaus SJ
J Gen Intern Med; 2006 Nov; 21(11):C3-5. PubMed ID: 17026723
[TBL] [Abstract][Full Text] [Related]
33. Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B: a case report.
Tanaka M; Setoguchi T; Ishidou Y; Arishima Y; Hirotsu M; Saitoh Y; Nakamura S; Kakoi H; Nagano S; Yokouchi M; Kamizono J; Komiya S
Diagn Pathol; 2012 Aug; 7():108. PubMed ID: 22906214
[TBL] [Abstract][Full Text] [Related]
34. Second tenofovir phase III study for the chronic HBV reaches primary endpoint.
AIDS Patient Care STDS; 2007 Aug; 21(8):607-8. PubMed ID: 17907310
[No Abstract] [Full Text] [Related]
35. Tenofovir-associated Fanconi syndrome in a patient with chronic hepatitis B.
Samarkos M; Theofanis V; Eliadi I; Vlachogiannakos J; Polyzos A
J Gastrointestin Liver Dis; 2014 Sep; 23(3):342. PubMed ID: 25267967
[No Abstract] [Full Text] [Related]
36. Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report.
Xiang Q; Liu Z; Yu Y; Zhang H; Xie Q; Mu G; Zhang J; Cen X; Cui Y
BMC Pharmacol Toxicol; 2020 Jun; 21(1):43. PubMed ID: 32503675
[TBL] [Abstract][Full Text] [Related]
37. [A Case of Tenofovir-associated Fanconi Syndrome in Patient with Chronic Hepatitis B].
Kim D; Lee J; Kim DH; Kang K; Suh SJ; Jung YK; Yim HJ
Korean J Gastroenterol; 2016 Dec; 68(6):317-320. PubMed ID: 28025475
[TBL] [Abstract][Full Text] [Related]
38. Replacement of tenofovir with adefovir may result in reactivation of hepatitis B virus replication.
Schildgen O; Hartmann H; Gerlich WH
Scand J Gastroenterol; 2006 Feb; 41(2):245-6. PubMed ID: 16484132
[No Abstract] [Full Text] [Related]
39. Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection.
Jones J; Colquitt J; Shepherd J; Harris P; Cooper K
Health Technol Assess; 2010 May; 14 Suppl 1():23-9. PubMed ID: 20507800
[TBL] [Abstract][Full Text] [Related]
40. Acquired Fanconi syndrome associated with prolonged adefovir dipivoxil therapy in a chronic hepatitis B patient.
Law ST; Li KK; Ho YY
Am J Ther; 2013; 20(6):e713-6. PubMed ID: 21519215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
